Evaluation of drug-drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling

Abstract Pemigatinib is a potent inhibitor of fibroblast growth factor receptor being developed for oncology indications. It is primarily metabolized by cytochrome P450 (CYP) 3A4, and the ratio of estimated concentration over concentration required for 50% inhibition ratio for pemigatinib as an inhi...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Tao Ji (Dahkki), Xuejun Chen (Dahkki), Swamy Yeleswaram (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Wiley, 2022-07-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis